Browsing: Business

Merck, a global pharmaceutical giant, has inked a partnership with Japanese firm Daiichi Sankyo, valuing at $5.5 billion, to co-develop three advanced cancer therapies. Depending on the success of these pioneering cell-targeted treatments, the agreement could garner up to $22 billion

Solar stocks took a significant hit on Friday as Solaredge, a prominent solar product manufacturer, indicated a sharp decline in European demand. This warning further dampened the sentiment surrounding the renewable energy sector, which has already been grappling with challenges throughout

After releasing its Q3 financial results, Tesla’s stock took a significant hit, plummeting by nearly 10%. While the Q3 results did not meet market expectations, the stock remained stable initially, possibly buoyed by the much-anticipated Cybertruck delivery event announcement. However, the subsequent conference call

Luxury giant LVMH witnessed a dramatic plunge in its shares, falling by as much as 8% on Wednesday. This substantial dip came in the wake of the company’s announcement that its third-quarter revenue growth had decelerated significantly compared to the first half

Amidst a challenging global economic environment, Samsung, the South Korean tech juggernaut, anticipates a sharp 78% decline in its operating profit for the third quarter, reflecting the prolonged dampening demand for consumer electronics. On Wednesday, the company released its earnings forecast,

Sandoz’s entrance into the stock market on Wednesday faced a chillier reception than expected. The biosimilar and generic drugmaker, which recently parted ways from Swiss healthcare behemoth Novartis, began trading at a valuation of 10.3 billion Swiss francs ($11.2 billion). This valuation